Further research is needed on the prognostic significance of elevated cardiac troponins and ST-elevation as well as their relationship to myocardial infarction in critically ill patients. A guideline is also needed to advise treatment strategies in septic patients who develop STEMI/non-STEMI while being treated with other fibrinolytic agents not approved for myocardial infarction such as DrotAA.
APC: activated protein C; DrotAA: drotrecogin alfa (activated); ECG: electrocardiogram; EF: ejection fraction; ICU: intensive care unit; INR: international normalized ratio; MAP: mean arterial pressure; PTT: partial thromboplastin time; STEMI: ST-elevation myocardial infarction; TNK: tenecteplase
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
The authors declare that they have no competing interests.
LB collected and analyzed all patient data, conducted a literature review and was a major contributor in writing the manuscript. JS collected and analyzed data related to the patient's stay in the intensive care unit. JGP collected, interpreted and analyzed data related to cardiac investigation. RK analyzed all data pertinent to the case, conducted a literature review and was a major contributor in writing the manuscript. All authors read and approved the final manuscript.
- Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995, 273:117-123.
- Bernard GR, Vincent J, Laterre P, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher C: Efficacy and safety of recombinant Activated Protein C for severe sepsis. N Engl J Med 2001, 344:699-709.
- Wiedermann CJ, Kaneider NC: A meta-analysis of controlled trials of recombinant human activated protein C therapy in patients with sepsis. BMC Emerg Med 2005, 5:7.
- Krishnagopalan S, Kumar A, Parrillo JE, Kumar A: Myocardial dysfunction in the patient with sepsis. Curr Opin Crit Care 2002, 8:376-388.
- Ammann P, Maggiorini M, Bertel O, Haenseler E, Joller-Jemelka HI, Oechslin E, Minder EI, Rickli H, Fehr T: Troponin as risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol 2003, 41:2004-2009.
- Terradellas JB, Bellot JF, Saris AB, Gil CL, Torrallardona AT, Garriga JR: Acute and transient ST segment elevation during bacterial shock in seven patients without apparent heart disease. Chest 1982, 81:444-448.
- Relos RP, Hasinoff IK, Beilman GJ: Moderately elevated serum troponin concentrations are associated with increased morbidity and mortality rates in surgical intensive care unit patients. Crit Care Med 2003, 31:2598-2603.
- Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001, 27:1416-1421.
- Hashimoto M, Yamashita T, Oiwa K, Watanabe S, Giddings JC, Yamamoto J: Enhancement of endogenous plasminogen activator- induced thrombolysis by argatroban and APC and its control by TAFI, measured in an arterial thrombolysis model in vivo using rat mesenteric arterioles. Thromb Haemost 2002, 87:110-113.
- Sakamoto T, Ogawa H, Yasue H, Oda Y, Kitajima S, Tsumoto K, Mizokami H: Prevention of arterial reocclusion after thrombolysis with activated protein C: Comparison with heparin in a canine model of coronary artery thrombosis. Circulation 1994, 90:427-432.
- Sakamoto T, Ogawa H, Takazoe K, Yoshimura M, Shimomura H, Moriyama Y, Arai H, Okajima K: Effect of activated protein C on plasma plasminogen activator inhibitor activity in patients with acute myocardial infarction treated with alteplase. J Am Coll Cardiol 2003, 42:1389-1394.
- Prasa A, Lerman A, Rihal CS: Apical ballooning syndrome (Tako- Tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction). Am Heart J 2007, 155:408-416.
- Geng S, Mullany D, Fraser JF: Takotsubo cardiomyopathy associated with sepsis due to Streptococcus pneumoniae pneumonia. Crit Care Resusc 2008, 10:231-234.